You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GAD-Alum

Showing 1 - 25 of 327
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 1 Trial in Linköping (GAD-alum (Diamyd) 40 µg/mL)

Recruiting
  • Diabetes Mellitus, Type 1
  • GAD-alum (Diamyd) 40 μg/mL
  • Linköping, Sweden
    Kliniska Forskningsenheten (Hudmottagningen), Universitetssjukhu
Aug 17, 2022

Type I Diabetes Trial in Birmingham (Placebo GABA and Placebo GAD-alum, GABA and Placebo GAD-alum, Active Oral GABA and Active

Completed
  • Type I Diabetes
  • Placebo GABA and Placebo GAD-alum
  • +2 more
  • Birmingham, Alabama
    Children's of Alabama
May 2, 2022

Diabetes, Type 1, Prediabetic State Trial in Malmö (Alum-GAD, Vitamin D3)

Terminated
Has Results
  • Diabetes Mellitus, Type 1
  • Prediabetic State
  • Malmö, Sweden
    Clinical Research Center, Pediatric Endocrinology, Jan Waldenstr
Oct 27, 2020

Diabetes, Type 1 Trial in Sweden (GAD-Alum, Vitamin D, Etanercept)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • GAD-Alum
  • +2 more
  • Helsingborg, Sweden
  • +7 more
Mar 26, 2021

Diabetes, Type 1 Trial in Linköping (GAD-Alum, Vitamin D)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • GAD-Alum
  • Vitamin D
  • Linköping, Sweden
    Linköping University
Apr 15, 2020

Type 1 Diabetes Trial in Canada, United States (GAD-Alum, GAD-Alum and Aluminum hydroxide, Aluminum hydroxide)

Completed
Has Results
  • Type 1 Diabetes Mellitus
  • GAD-Alum
  • +2 more
  • Los Angeles, California
  • +14 more
Apr 27, 2020

Prediabetes, Type 1 Diabetes Trial in Malmö (Placebo comparator, Diamyd)

Completed
Has Results
  • Prediabetes
  • Type 1 Diabetes
  • Malmö, Sweden
    Clinical Research Center, Pediatric Endocrinology, Jan Waldenstr
May 2, 2019

Diabetes, Type I, Enterovirus Infections, Autoimmunity Trial in Oslo (GAD-alum, Placebo)

Terminated
  • Diabetes, Type I
  • +2 more
  • GAD-alum
  • Placebo
  • Oslo, Norway
    Endokrinologisk poliklinikk, Oslo Universitetssykehus Aker
May 14, 2018

Clinical Markers of Panic and Generalized Anxiety Disorder

Completed
  • Generalized Anxiety Disorder
  • +2 more
  • Structured Clinical Interview for DSM-5
  • Monza, MB, Italy
    University of Milano Bicocca - Fondazione IRCCS San Gerardo dei
Oct 4, 2023

Chronic HIV Infection Trial in United States (426c.Mod.Core-C4b, Adjuvant 3M-052-AF+Alum)

Not yet recruiting
  • Chronic HIV Infection
  • 426c.Mod.Core-C4b
  • Adjuvant 3M-052-AF+Alum
  • Birmingham, Alabama
  • +6 more
Aug 17, 2023

Anxiety in Relation to Nausea and Vomiting in Pregnancy

Recruiting
  • Nausea Gravidarum
  • Anxiety
  • PUQE score
  • GAD-7
  • Cairo, Egypt
    Ain Shams Maternity Hospital
Sep 22, 2023

Anxiety Disorders Trial in Taipei (AI-fNIRS neurofeedback device, AI-fNIRS neurofeedback device with sham signals)

Recruiting
  • Anxiety Disorders
  • AI-fNIRS neurofeedback device
  • AI-fNIRS neurofeedback device with sham signals
  • Taipei, Taiwan
    National Taiwan University Hospital
Jun 26, 2023

Generalized Anxiety Disorder Trial in Bergen (Cognitive Behavioural Therapy, Physical Exercise, Placebo control)

Active, not recruiting
  • Generalized Anxiety Disorder
  • Cognitive Behavioural Therapy
  • +2 more
  • Bergen, Nesttun, Norway
    Solli DPS
Nov 23, 2022

Generalized Anxiety Disorder Trial in Decatur (CYB004, Psychotherapy)

Not yet recruiting
  • Generalized Anxiety Disorder
  • Decatur, Georgia
    iResearch Atlanta
Sep 20, 2023

Chikungunya Virus Trial in Lenexa (CHIKV VLP, adjuvanted)

Completed
  • Chikungunya Virus
  • CHIKV VLP, adjuvanted
  • Lenexa, Kansas
    Johnson County ClinTrials
Jul 18, 2022

Generalized Anxiety Disorder Trial in Stockholm (ICBT-IU)

Recruiting
  • Generalized Anxiety Disorder
  • ICBT-IU
  • Stockholm, Huddinge, Sweden
    Internet Psychiatry Clinic, Psychiatry Southwest, SLSO, Region S
Apr 17, 2023

Parkinson Disease Trial in United States (AAV-GAD)

Enrolling by invitation
  • Parkinson Disease
  • AAV-GAD
  • West Bloomfield, Michigan
  • +4 more
Jun 7, 2023

Central Nervous Medications on Physical Conditions in Sleep

Completed
  • Anxiety Disorders
  • Sleep Apnea
  • Taipei, Neihu, Taiwan
    Tri-Service General Hospital
Mar 18, 2022

Generalized Anxiety Disorder Trial (ENX-102, Placebo)

Not yet recruiting
  • Generalized Anxiety Disorder
  • (no location specified)
Feb 28, 2023

Healthy Volunteers Patients With Generalized Anxiety Disorder (GAD) Trial in Grayslake (ABBV-932, Placebo for ABBV-932)

Not yet recruiting
  • Healthy Volunteers Patients With Generalized Anxiety Disorder (GAD)
  • Grayslake, Illinois
    Acpru /Id# 255945
Aug 30, 2023

Generalized Anxiety Disorder Trial in Chapel Hill (At-Home Stimulation)

Not yet recruiting
  • Generalized Anxiety Disorder
  • At-Home Stimulation
  • Chapel Hill, North Carolina
    Carolina Center for Neurostimulation
Nov 3, 2023

COVID-19 Trial in Semarang, Jakarta (SARS-CoV-2 protein subunit recombinant vaccine, SARS-CoV-2 inactivated vaccine)

Active, not recruiting
  • COVID-19
  • SARS-CoV-2 protein subunit recombinant vaccine
  • SARS-CoV-2 inactivated vaccine
  • Semarang, Central Java, Indonesia
  • +1 more
Aug 8, 2022

Anxiety, Generalized Anxiety Disorder Trial in Kingston (e-CBT, Mental Health Coaching)

Active, not recruiting
  • Anxiety
  • Generalized Anxiety Disorder
  • e-CBT
  • Mental Health Coaching
  • Kingston, Ontario, Canada
    Hotel Dieu Hospital
Dec 20, 2022

HIV-1-infection Trial in New York, Philadelphia, Nashville (INO-6160, 2 mg, Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500

Recruiting
  • HIV-1-infection
  • INO-6160, 2 mg
  • Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500 mcg)
  • New York, New York
  • +2 more
Apr 13, 2023

Interference Between Oral Anticoagulants and Heparin During

Recruiting
  • Atrial Fibrillation
  • Atrial Tachycardia
    • Paris, France
      Hopital Bichat-Claude Bernard
    Mar 27, 2023